Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device User Fee Negotiations: Here We Go Again

This article was originally published in The Gray Sheet

Executive Summary

FDA is holding a meeting Sept. 14 to start a public dialogue on the next reauthorization of medical device user fees, more than two years before Congress needs to renew the program

You may also be interested in...



User Fees Should Support Post-Market Safety, Consumer Groups Say

Medical and consumer groups say future user fees should go toward ensuring device safety, not just toward speeding up product approvals.

User Fees Should Support Post-Market Safety, Consumer Groups Say

Medical and consumer groups say future user fees should go toward ensuring device safety, not just toward speeding up product approvals.

FDA User Fee Renewal Should Include Pre-Market Improvements - Industry

Consumer advocates are suggesting FDA request considerably more funding from device companies in the next round of user fee negotiations, but companies are reluctant to foot more of the bill for device reviews without seeing promised improvements in FDA's pre-market program

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel